These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28722474)

  • 21. Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cells.
    Granchi C; Roy S; Giacomelli C; Macchia M; Tuccinardi T; Martinelli A; Lanza M; Betti L; Giannaccini G; Lucacchini A; Funel N; León LG; Giovannetti E; Peters GJ; Palchaudhuri R; Calvaresi EC; Hergenrother PJ; Minutolo F
    J Med Chem; 2011 Mar; 54(6):1599-612. PubMed ID: 21332213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent Development of Small Molecule Glutaminase Inhibitors.
    Song M; Kim SH; Im CY; Hwang HJ
    Curr Top Med Chem; 2018; 18(6):432-443. PubMed ID: 29793408
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitors of lactate dehydrogenase isoforms and their therapeutic potentials.
    Granchi C; Bertini S; Macchia M; Minutolo F
    Curr Med Chem; 2010; 17(7):672-97. PubMed ID: 20088761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery and Evaluation of PRL Trimer Disruptors for Novel Anticancer Agents.
    Bai Y; Yu ZH; Zhang ZY
    Methods Mol Biol; 2016; 1447():121-38. PubMed ID: 27514804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small-molecule PARP modulators--current status and future therapeutic potential.
    Penning TD
    Curr Opin Drug Discov Devel; 2010 Sep; 13(5):577-86. PubMed ID: 20812149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A unique small molecule inhibitor of enolase clarifies its role in fundamental biological processes.
    Jung DW; Kim WH; Park SH; Lee J; Kim J; Su D; Ha HH; Chang YT; Williams DR
    ACS Chem Biol; 2013; 8(6):1271-82. PubMed ID: 23547795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. H3K36 methyltransferases as cancer drug targets: rationale and perspectives for inhibitor development.
    Rogawski DS; Grembecka J; Cierpicki T
    Future Med Chem; 2016 Sep; 8(13):1589-607. PubMed ID: 27548565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of small molecule isozyme non-specific inhibitors of mammalian acetyl-CoA carboxylase 1 and 2.
    Corbett JW; Freeman-Cook KD; Elliott R; Vajdos F; Rajamohan F; Kohls D; Marr E; Zhang H; Tong L; Tu M; Murdande S; Doran SD; Houser JA; Song W; Jones CJ; Coffey SB; Buzon L; Minich ML; Dirico KJ; Tapley S; McPherson RK; Sugarman E; Harwood HJ; Esler W
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2383-8. PubMed ID: 20219367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the differential action on cancer cells of LDH-A inhibitors based on the N-hydroxyindole-2-carboxylate (NHI) and malonic (Mal) scaffolds.
    Granchi C; Calvaresi EC; Tuccinardi T; Paterni I; Macchia M; Martinelli A; Hergenrother PJ; Minutolo F
    Org Biomol Chem; 2013 Oct; 11(38):6588-96. PubMed ID: 23986182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent progress in the discovery of small-molecule inhibitors of the HMT EZH2 for the treatment of cancer.
    Verma SK; Knight SD
    Future Med Chem; 2013 Sep; 5(14):1661-70. PubMed ID: 24047271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural characteristics of small-molecule inhibitors targeting
    Gao S; Li X; Zhang M; Zhang N; Wang R; Chang J
    Future Med Chem; 2021 Sep; 13(17):1475-1489. PubMed ID: 34240624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An update of new small-molecule anticancer drugs approved from 2015 to 2020.
    Liang X; Wu P; Yang Q; Xie Y; He C; Yin L; Yin Z; Yue G; Zou Y; Li L; Song X; Lv C; Zhang W; Jing B
    Eur J Med Chem; 2021 Aug; 220():113473. PubMed ID: 33906047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EDITORIAL: Advances in Developing Versatile Tools for the Discovery of Novel Therapeutics.
    Hu Y
    Curr Top Med Chem; 2017; 17(20):2233-2234. PubMed ID: 28799501
    [No Abstract]   [Full Text] [Related]  

  • 34. Lactate dehydrogenase inhibition: exploring possible applications beyond cancer treatment.
    Di Stefano G; Manerba M; Di Ianni L; Fiume L
    Future Med Chem; 2016 Apr; 8(6):713-25. PubMed ID: 27054686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural and functional regulation of lactate dehydrogenase-A in cancer.
    Woodford MR; Chen VZ; Backe SJ; Bratslavsky G; Mollapour M
    Future Med Chem; 2020 Mar; 12(5):439-455. PubMed ID: 32064930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of human lactate dehydrogenase 5 inhibitors (hLDH5) with anti-lung cancer activity through an in silico method and biological validation.
    He S; Wang Q
    Bioorg Med Chem Lett; 2019 Sep; 29(17):2459-2463. PubMed ID: 31345633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activators of PKM2 in cancer metabolism.
    Warner SL; Carpenter KJ; Bearss DJ
    Future Med Chem; 2014 Jun; 6(10):1167-78. PubMed ID: 25078136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fragment growing and linking lead to novel nanomolar lactate dehydrogenase inhibitors.
    Kohlmann A; Zech SG; Li F; Zhou T; Squillace RM; Commodore L; Greenfield MT; Lu X; Miller DP; Huang WS; Qi J; Thomas RM; Wang Y; Zhang S; Dodd R; Liu S; Xu R; Xu Y; Miret JJ; Rivera V; Clackson T; Shakespeare WC; Zhu X; Dalgarno DC
    J Med Chem; 2013 Feb; 56(3):1023-40. PubMed ID: 23302067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer stem cells as a target population for drug discovery.
    Bouvard C; Barefield C; Zhu S
    Future Med Chem; 2014 Sep; 6(14):1567-85. PubMed ID: 25367391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting Histone Acetyltransferase MOZ/KAT6A as a New Avenue for Hematological Tumor Therapy.
    Zhou C; Zhu HL; Duan Y
    Curr Top Med Chem; 2020; 20(5):333-335. PubMed ID: 32242512
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.